chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 71.0
Sex: U
Vaccine: COVID19-2, COVID19-2
Symptoms: Expired product administered, No adverse event
Clinical narrative: bivalent dose, was documented by HCP to expire on 3-17-23; no adverse event; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (bivalent dose, was documented by HCP to expire on 3-17-23) and NO ADVERSE EVENT (no adverse event) in a 71-year-old patient of an unknown gender who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. 044H22A) for COVID-19 prophylaxis.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) 1 dosage form. On an unknown date, the patient experienced EXPIRED PRODUCT ADMINISTERED (bivalent dose, was documented by HCP to expire on 3-17-23) and NO ADVERSE EVENT (no adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (bivalent dose, was documented by HCP to expire on 3-17-23) and NO ADVERSE EVENT (no adverse event) outcome was unknown.        For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Unknown), the reporter considered NO ADVERSE EVENT (no adverse event) to be not related. No further causality assessment was provided for EXPIRED PRODUCT ADMINISTERED (bivalent dose, was documented by HCP to expire on 3-17-23).    No concomitant medication were reported. HCP advised that 2 vials from the lot number were used to administer vaccinations for 3 patients. No treatment information was provided by the reporter.   This case was linked to US-MODERNATX, INC.-MOD-2023-716749, US-MODERNATX, INC.-MOD-2023-716751 (E2B Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2023-716749:(Patient No 2 with patient initial) US-MODERNATX, INC.-MOD-2023-716751:(Patient 3 with Initials)
Sex: U
Vaccine: COVID19-2
Symptoms: Circumstance or information capable of leading to medication error, No adverse event
Clinical narrative: we do not know what was given and it could be potentially the wrong vaccine so we are just reporting to make sure it is documented; no adverse event; This spontaneous case was reported by an other health care professional and describes the occurrence of CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR (we do not know what was given and it could be potentially the wrong vaccine so we are just reporting to make sure it is documented) and NO ADVERSE EVENT (no adverse event) in an adult patient of an unknown gender who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. 044C22A) for COVID-19 prophylaxis.     No Medical History information was reported.    In August 2022, the patient received dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR (we do not know what was given and it could be potentially the wrong vaccine so we are just reporting to make sure it is documented) and NO ADVERSE EVENT (no adverse event). At the time of the report, CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR (we do not know what was given and it could be potentially the wrong vaccine so we are just reporting to make sure it is documented) and NO ADVERSE EVENT (no adverse event) outcome was unknown.        The action taken with mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Intramuscular) was unknown.   For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Intramuscular), the reporter considered CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR (we do not know what was given and it could be potentially the wrong vaccine so we are just reporting to make sure it is documented) to be related. No further causality assessment was provided for NO ADVERSE EVENT (no adverse event).    No treatment medications were reported No concomitant medications were reported  She is calling just to see what vaccine was given to a patient she can not tell if it was monovalent or bivalent so i am transferring her the Lot # is 044C22A Vaccine was given in August 2022 it was the history of the patient so this is an AE because we do not know what was given and it could be potentially the wrong vaccine so we are just reporting to make sure it is documented
Sex: M
Vaccine: COVID19-2
Symptoms: Extra dose administered, No adverse event
Clinical narrative: a second Moderna Bivalent booster was given; No adverse event; This spontaneous case was reported by a pharmacist and describes the occurrence of EXTRA DOSE ADMINISTERED (a second Moderna Bivalent booster was given) and NO ADVERSE EVENT (No adverse event) in an adult male patient who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) for COVID-19 prophylaxis.     It was unknown whether patient received any other vaccines in the 4 weeks prior to COVID-19 vaccine.     On an unknown date, the patient received dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) 1 dosage form. On an unknown date, the patient experienced EXTRA DOSE ADMINISTERED (a second Moderna Bivalent booster was given) and NO ADVERSE EVENT (No adverse event). At the time of the report, EXTRA DOSE ADMINISTERED (a second Moderna Bivalent booster was given) and NO ADVERSE EVENT (No adverse event) outcome was unknown.        For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for EXTRA DOSE ADMINISTERED (a second Moderna Bivalent booster was given).    No concomitant medications was provided. Patient received all previous doses of Moderna. No treatment medications was provided.   Reporter did not allow further contact
Sex: M
Vaccine: COVID19-2
Symptoms: No adverse event, Wrong product administered
Clinical narrative: Wrong vaccine administered; No Adverse Event; This spontaneous case was reported by a patient and describes the occurrence of WRONG PRODUCT ADMINISTERED (Wrong vaccine administered) and NO ADVERSE EVENT (No Adverse Event) in an adult male patient who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) for COVID-19 prophylaxis.   No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) 1 dosage form. On an unknown date, the patient experienced WRONG PRODUCT ADMINISTERED (Wrong vaccine administered) and NO ADVERSE EVENT (No Adverse Event). At the time of the report, WRONG PRODUCT ADMINISTERED (Wrong vaccine administered) and NO ADVERSE EVENT (No Adverse Event) outcome was unknown.     For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Unknown), the reporter considered NO ADVERSE EVENT (No Adverse Event) to be not related. No further causality assessment was provided for WRONG PRODUCT ADMINISTERED (Wrong vaccine administered).    No concomitant medications were reported.  Patient states that he was required to get a COVID-19 vaccine for immigration purposes. Patient went to a drug store and was administered a dose of the Moderna COVID-19 bivalent vaccine. Patient then mentioned that had not previously received the primary series or any doses of the Moderna COVID-19 vaccine. Patient wanted to know if this was the only vaccination needed or did he need any additional doses were needed.  No treatment information was provided.   Reporter did not allow further contact
Age: 75.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19
Clinical narrative: caught covid 10 days after booster dose; This spontaneous case was reported by a patient and describes the occurrence of COVID-19 (caught covid 10 days after booster dose) in a 75-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 061F22A) for COVID-19 prophylaxis.     Previously administered products included for Product used for unknown indication: PFIZER BIONTECH COVID-19 VACCINE (Dose 1, Lot Number:EM9810) on 05-Feb-2021, PFIZER BIONTECH COVID-19 VACCINE (Dose 3, Lot Number: FF2588), PFIZER BIONTECH COVID-19 VACCINE (Dose 2 and Lot Number:EN6205). Past adverse reactions to the above products included No adverse event with PFIZER BIONTECH COVID-19 VACCINE, PFIZER BIONTECH COVID-19 VACCINE and PFIZER BIONTECH COVID-19 VACCINE.    In April 2022, the patient received fifth dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. In April 2022, the patient experienced COVID-19 (caught covid 10 days after booster dose). At the time of the report, COVID-19 (caught covid 10 days after booster dose) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   The patient received the additional booster around 15-Apr-2022 and had COVID-19 vaccine, 10 days after the booster dose. The patient received the last booster as Moderna bivalent on 22-Oct-2022.  The concomitant medication was not reported.  The patient received the fourth dose of Moderna vaccine with batch number as 005M21A.  The treatment medication was not reported.
Sex: M
Vaccine: COVID19-2
Symptoms: Extra dose administered, No adverse event
Clinical narrative: 2nd dose of the Moderna COVID-19 bivalent vaccine was administered to a patient in error; No adverse event; This spontaneous case was reported by a pharmacist and describes the occurrence of EXTRA DOSE ADMINISTERED (2nd dose of the Moderna COVID-19 bivalent vaccine was administered to a patient in error) and NO ADVERSE EVENT (No adverse event) in an adult male patient who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) for COVID-19 prophylaxis.     No Medical History information was reported.  On an unknown date, the patient received dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) 1 dosage form. On an unknown date, the patient experienced EXTRA DOSE ADMINISTERED (2nd dose of the Moderna COVID-19 bivalent vaccine was administered to a patient in error) and NO ADVERSE EVENT (No adverse event). At the time of the report, EXTRA DOSE ADMINISTERED (2nd dose of the Moderna COVID-19 bivalent vaccine was administered to a patient in error) and NO ADVERSE EVENT (No adverse event) outcome was unknown.     For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for EXTRA DOSE ADMINISTERED (2nd dose of the Moderna COVID-19 bivalent vaccine was administered to a patient in error).    No concomitant medications were reported.  The patient had not reported any adverse reactions at this time.   The healthcare professional (HCP) was calling to see if there are any unique side effects associated with the administration of a 2nd bivalent booster dose of the Moderna COVID-19 vaccine.  No treatment medications were reported.
Age: 1.25
Sex: F
Vaccine: HIBV
Symptoms: Expired product administered, No adverse event
Clinical narrative: an expired dose of ACTHIB was administered to a patient with no reported adverse event; Initial information received on 21-Mar-2023 regarding an unsolicited valid non-serious case received from a healthcare professional.  This case involves a 15-month-old female, to whom an expired dose of HIB (PRP/T) VACCINE [ACT-HIB] was administered to a patient with no reported adverse event.  The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.  Concomitant medications included DIPHTHERIA VACCINE TOXOID, PERTUSSIS VACCINE ACELLULAR, TETANUS VACCINE TOXOID (DAPTACEL) for Prophylactic vaccination.  On 20-Mar-2023, the patient received a Booster dose at 0.5ml total of suspect HIB (PRP/T) VACCINE Powder and solvent for solution for injection (Strength: standard) (lot number: UJ665AA, expiry date: 11-Mar-2023) via intramuscular route in the left vastus lateralis for Immunization and on the same day an expired dose of acthib was administered to a patient with no reported adverse event (expired product administered).  It was reported, caller requesting validity and safety information.   Action taken with HAEMOPHILUS TYPE B (HIB) VACCINE (ACT-HIB) was not applicable.  At time of reporting, the outcome was Unknown.  This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the guidelines. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.
Sex: M
Vaccine: FLU4
Symptoms: Asthenia, Depressed mood, Gait disturbance, General physical health deterioration, Guillain-Barre syndrome
Clinical narrative: Guillaine Barre; barely walk; barely walk has to walk with a cane; After getting the flu shot that went downhill; Condition worsened; has to walk with a cane and very weak; Initial information received on 21-Mar-2023 regarding an unsolicited valid serious case received from a patient.  This case involves an unknown age male patient who had guillaine barre, barely walk, barely walk has to walk with a cane, after getting the flu shot that went downhill, condition worsened and very weak after receiving influenza quadrival A-B high dose HV vaccine [Fluzone High-Dose Quadrivalent].  The patient's past medical history, medical treatment(s), vaccination(s), concomitant(s) and family history were not provided.   On an unknown date in Oct-2021, the patient received an unknown dose of suspect influenza quadrival A-B high dose HV vaccine (With unknown formulation, strength, route, lot number, expiration and at unknown administration site) for prophylactic vaccination (immunization).  On an unknown date, patient developed guillaume barre (guillain-barre syndrome) barely walk (gait disturbance), barely walk has to walk with a cane (walking aid user), after getting the flu shot that went downhill (depressed mood), condition worsened (condition aggravated) and has to walk with a cane and very weak (asthenia) (unknown latency) following the administration of influenza quadrival A-B high dose HV vaccine  Relevant laboratory test results included: Lumbar puncture - On an unknown date: [it stated that he had GBS (guillain-barre syndrome)]  Action taken: not applicable.  Caller states that he is having an intravenous procedure to help in form of treatment.  At time of reporting, the outcome was Unknown for all events.   Seriousness criteria: hospitalized and medically significant for guillain-barre syndrome.; Sender's Comments: Sanofi company comment dated 23-Mar-2023: This case involves an unknown age male patient who had guillaine barre, barely walk, barely walk has to walk with a cane, after getting the flu shot that went downhill, condition worsened and very weak after receiving influenza quadrival A-B high dose HV vaccine [Fluzone High-Dose Quadrivalent]. The clinical course of the event was not provided. Furthermore, information regarding condition at the time of vaccination, role of medical history, concomitants, lab data excluding other predisposing etiologies would be needed for complete assessment of the case. Based on information provided, the role of an suspect vaccine cannot be assessed.
Sex: M
Vaccine: FLU4
Symptoms: Lumbar puncture abnormal, Walking aid user
Clinical narrative: Guillaine Barre; barely walk; barely walk has to walk with a cane; After getting the flu shot that went downhill; Condition worsened; has to walk with a cane and very weak; Initial information received on 21-Mar-2023 regarding an unsolicited valid serious case received from a patient.  This case involves an unknown age male patient who had guillaine barre, barely walk, barely walk has to walk with a cane, after getting the flu shot that went downhill, condition worsened and very weak after receiving influenza quadrival A-B high dose HV vaccine [Fluzone High-Dose Quadrivalent].  The patient's past medical history, medical treatment(s), vaccination(s), concomitant(s) and family history were not provided.   On an unknown date in Oct-2021, the patient received an unknown dose of suspect influenza quadrival A-B high dose HV vaccine (With unknown formulation, strength, route, lot number, expiration and at unknown administration site) for prophylactic vaccination (immunization).  On an unknown date, patient developed guillaume barre (guillain-barre syndrome) barely walk (gait disturbance), barely walk has to walk with a cane (walking aid user), after getting the flu shot that went downhill (depressed mood), condition worsened (condition aggravated) and has to walk with a cane and very weak (asthenia) (unknown latency) following the administration of influenza quadrival A-B high dose HV vaccine  Relevant laboratory test results included: Lumbar puncture - On an unknown date: [it stated that he had GBS (guillain-barre syndrome)]  Action taken: not applicable.  Caller states that he is having an intravenous procedure to help in form of treatment.  At time of reporting, the outcome was Unknown for all events.   Seriousness criteria: hospitalized and medically significant for guillain-barre syndrome.; Sender's Comments: Sanofi company comment dated 23-Mar-2023: This case involves an unknown age male patient who had guillaine barre, barely walk, barely walk has to walk with a cane, after getting the flu shot that went downhill, condition worsened and very weak after receiving influenza quadrival A-B high dose HV vaccine [Fluzone High-Dose Quadrivalent]. The clinical course of the event was not provided. Furthermore, information regarding condition at the time of vaccination, role of medical history, concomitants, lab data excluding other predisposing etiologies would be needed for complete assessment of the case. Based on information provided, the role of an suspect vaccine cannot be assessed.
Age: 23.0
Sex: F
Vaccine: TDAP
Symptoms: Expired product administered, Medication error, No adverse event
Clinical narrative: inadvertently administered an expired dose of adacel prefilled syringe with no reported adverse event; Initial information received on 21-Mar-2023 regarding an unsolicited valid non-serious case received from a other health professional.  This case involves a 23 years old female patient who was administered an expired dose of Diphtheria-2/Tetanus/5 Ac Pertussis Vaccine [Adacel] prefilled syringe with no reported adverse event.  The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.  Concomitant medications included Meningococcal Vaccine A/C/Y/W Conj (Crm197) (Menveo) for Prophylactic vaccination.  On 20-Mar-2023, the patient received 0.5 ml Total (1X) of suspect Diphtheria-2/Tetanus/5 Ac Pertussis Vaccine Suspension for injection (lot number: U6923AA, Expiry date: 21-Jan-2023) (with an unknown strength) via intramuscular route in the left deltoid for immunization.  On 20-Mar-2023, the patient was administered an expired dose of Diphtheria-2/Tetanus/5 Ac Pertussis Vaccine prefilled syringe with no reported adverse event (expired product administered) (Latency: same day).  It was reported, Caller stated that they administered a dose to a patient, but the dose expired 21Jan2023. Caller is asking for efficacy information or any possible side effects they should watch out for.  Action taken: not applicable.  Outcome: Unknown   This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the guidelines. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.
Age: 1.0
Sex: M
Vaccine: UNK
Symptoms: Expired product administered, No adverse event
Clinical narrative: an expired pentacel was given to a patient with no reported adverse event; Initial information received on 21-Mar-2023 regarding an unsolicited valid  non-serious case received from an other health professional.  This case involves a 1 years old male patient to whom an expired diphtheria/tetanus/5 hybrid AC pertussis/IPV(VERO)/HIB(PRP/T) vaccine [Pentacel (VERO)] was given with no reported adverse event.  The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.  Concomitant medications included hepatitis A vaccine INACT (HAVRIX) for Prophylactic vaccination.  On 21-Mar-2023, the patient received 0.25 ml (milliliter) of suspect diphtheria/tetanus/5 hybrid AC pertussis/IPV(VERO)/HIB(PRP/T) vaccine, suspension for injection(lot number: UJ613AAA, expiry date: 25-Feb-2023) (1x) (once) (With unknown strength) via intramuscular route in the right thigh for immunization.  On 21-Mar-2023 the reporter reported that an expired pentacel was given to a patient with no reported adverse event (expired product administered) (latency: same day).  No lab data were reported.  Action taken: not applicable.  At time of reporting, the outcome was Unknown for an event.   This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the guidelines. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.
Age: 3.0
Sex: M
Vaccine: DTAP
Symptoms: Injection site swelling
Clinical narrative: rash was generally all over; injection site was left deltoid and was descried as a little swollen; injection site was left deltoid and was descried as a tender; Initial information received on 21-Mar-2023 regarding an unsolicited valid non-serious case received from other health professional.  This case involves a 3 years old male patient who had rash was generally all over, injection site was left deltoid and was descried as a little swollen and injection site was left deltoid and was descried as a tender after receiving diphtheria-15/tetanus/5 AC pertussis vaccine [Daptacel].   The patient's past medical history, medical treatment(s), vaccination(s), concomitant(s)and family history were not provided.    On 16-Mar-2023, the patient received a dose 4 at 0.5 mL dose of suspect diphtheria-15/tetanus/5 AC pertussis vaccine, Suspension for injection, strength: standard, lot number: C5864AA, expiry date: 07-Apr-2023, via intramuscular route in the left deltoid for immunisation.  On an unknown date the patient had rash was generally all over (rash), injection site was left deltoid and was descried as a little swollen (injection site swelling) and injection site was left deltoid and was descried as a tender (injection site pain) (unknown latency) following the administration of diphtheria-15/tetanus/5 AC pertussis vaccine.  No lab data was reported.  Action taken was not applicable.  It was not reported if the patient received a corrective treatment for the events.  At time of reporting, the outcome was Unknown for the events.
Age: 82.0
Sex: M
Vaccine: COVID19-2, FLU4
Symptoms: COVID-19, Cough, Fatigue, Headache, Myalgia
Clinical narrative: It started off with a dry cough, sore muscles, headache, tiredness and slight fever 99.0. I took at home COVID-19 test on 03/16/2023. I then had a telehealth visit with my provider and was prescribed Paxlovid for 5 days. My symptoms were more severe on 03/16/2023 and 03/17/2023 with cough, fatigue, and pain. Also wanted to note with Paxlovid, it left a bad taste in my mouth. I will be taking another at home COVID-19 test tomorrow on 03/25/2023.
Age: 82.0
Sex: M
Vaccine: COVID19-2, FLU4
Symptoms: Pain, Pyrexia, SARS-CoV-2 test positive
Clinical narrative: It started off with a dry cough, sore muscles, headache, tiredness and slight fever 99.0. I took at home COVID-19 test on 03/16/2023. I then had a telehealth visit with my provider and was prescribed Paxlovid for 5 days. My symptoms were more severe on 03/16/2023 and 03/17/2023 with cough, fatigue, and pain. Also wanted to note with Paxlovid, it left a bad taste in my mouth. I will be taking another at home COVID-19 test tomorrow on 03/25/2023.
Age: 66.0
Sex: F
Vaccine: COVID19
Symptoms: Balance disorder, Dizziness, Laboratory test, Vestibular disorder
Clinical narrative: In 2022, around the end of July or in August, I noticed I was having general dizziness and unsteady on my feet.  It would last maybe 30-40 seconds.  A month later I had another episode that lasted about 5 minutes and I had to sit down.  The third episode lasted about 2-3 hours.  I visited a cardiologist at a regularly scheduled.    I began physical therapy for 4 weeks.  I was diagnosed with vestibular hypofunction. Since then, I have had a couple of episodes but after I do my exercises it resolves.
Age: 72.0
Sex: F
Vaccine: COVID19-2
Symptoms: COVID-19, Cough, Diarrhoea, Feeling abnormal, Oropharyngeal pain
Clinical narrative: It started out with an itchy throat. The next day I had a sore throat. The next day I had cough and congestion. The next day I developed diarrhea. Then I was riding up a storm for the like the next 3 days. After about a week I was feeling better.
Age: 72.0
Sex: F
Vaccine: COVID19-2
Symptoms: Respiratory tract congestion, SARS-CoV-2 test positive, Throat irritation
Clinical narrative: It started out with an itchy throat. The next day I had a sore throat. The next day I had cough and congestion. The next day I developed diarrhea. Then I was riding up a storm for the like the next 3 days. After about a week I was feeling better.
Age: 27.0
Sex: F
Vaccine: FLUC4, HEP
Symptoms: Headache, Pyrexia, Vision blurred, Vomiting
Clinical narrative: Pt called with c/o h/a and blurred vision.  States intermittent h/a started1  day after receiving Hep B #3 and Flu vaccines on 3/6.  Reports 1 episode of vomiting and mild fever on 3/7 as well with no further reports of these s/s after 3/7.   States blurred vision started about 1 wk after vaccination.  States she notices the blurred vision when she goes to read and the h/a occurs about q3 days.  States she rests to relieve the h/a and has not had to take any medication.  Advised her to f/u with an Optometrist/Ophthalmologist and if symptoms worsen, advised to present to an Urgent care for further evaluation.  Pt's intermittent h/a and blurred vision appear to be unrelated to immunizations.  Pt verbalized understanding of info provided and has no further questions or concerns at this time.
Age: 57.0
Sex: M
Vaccine: VARZOS
Symptoms: Blister, Rash erythematous
Clinical narrative: After first dose of shingrix patient developed red rash and blister.
Age: 64.0
Sex: F
Vaccine: COVID19-2
Symptoms: Extra dose administered, No adverse event
Clinical narrative: No adverse event, administration error only. Client received 2nd dose of Bivalent booster inadvertently, 8 weeks after previous Bivalent booster dose
Age: 39.0
Sex: F
Vaccine: COVID19-2, COVID19, COVID19, COVID19-2
Symptoms: Anal incontinence, Back pain, CSF oligoclonal band present, CSF white blood cell count increased, Electromyogram normal
Clinical narrative: Muscle weakness, tingling and numbness throughout both lower extremities and saddle area, shooting pain down both legs, bladder and bowel incontinence, fatigue, pain throughout back
Age: 39.0
Sex: F
Vaccine: COVID19-2, COVID19, COVID19, COVID19-2
Symptoms: Fatigue, Hypoaesthesia, Lumbar puncture abnormal, Magnetic resonance imaging spinal normal, Muscular weakness
Clinical narrative: Muscle weakness, tingling and numbness throughout both lower extremities and saddle area, shooting pain down both legs, bladder and bowel incontinence, fatigue, pain throughout back
Age: 39.0
Sex: F
Vaccine: COVID19-2, COVID19, COVID19, COVID19-2
Symptoms: Nerve conduction studies normal, Pain, Pain in extremity, Paraesthesia, Scan with contrast normal
Clinical narrative: Muscle weakness, tingling and numbness throughout both lower extremities and saddle area, shooting pain down both legs, bladder and bowel incontinence, fatigue, pain throughout back
Age: 39.0
Sex: F
Vaccine: COVID19-2, COVID19, COVID19, COVID19-2
Symptoms: Urinary incontinence, Viral test negative
Clinical narrative: Muscle weakness, tingling and numbness throughout both lower extremities and saddle area, shooting pain down both legs, bladder and bowel incontinence, fatigue, pain throughout back
Age: 39.0
Sex: F
Vaccine: COVID19-2, COVID19, COVID19, COVID19-2
Symptoms: Anal incontinence, CSF oligoclonal band present, CSF white blood cell count increased, Fatigue, Hypoaesthesia
Clinical narrative: Muscle weakness, tingling and numbness throughout both lower extremities and saddle area, shooting pain down both legs, bladder and bowel incontinence, fatigue, pain throughout back
Age: 39.0
Sex: F
Vaccine: COVID19-2, COVID19, COVID19, COVID19-2
Symptoms: Lumbar puncture abnormal, Magnetic resonance imaging head normal, Magnetic resonance imaging spinal normal, Muscular weakness, Pain in extremity
Clinical narrative: Muscle weakness, tingling and numbness throughout both lower extremities and saddle area, shooting pain down both legs, bladder and bowel incontinence, fatigue, pain throughout back
Age: 39.0
Sex: F
Vaccine: COVID19-2, COVID19, COVID19, COVID19-2
Symptoms: Paraesthesia, Urinary incontinence
Clinical narrative: Muscle weakness, tingling and numbness throughout both lower extremities and saddle area, shooting pain down both legs, bladder and bowel incontinence, fatigue, pain throughout back
Age: 0.33
Sex: M
Vaccine: DTAPHEPBIP, HIBV, PNC13, RV1
Symptoms: Chills, Enterovirus test positive, Human rhinovirus test positive, Seizure
Clinical narrative: Rigor vs seizure in the evening after immunizations. Evaluated and observed in ER.
Age: 75.0
Sex: M
Vaccine: COVID19-2
Symptoms: COVID-19, Fatigue, Feeling abnormal, SARS-CoV-2 test positive
Clinical narrative: I felt really terrible. I was just really fatigue. I tested positive for COVID-19 and on the same day I talked to my doctor. He prescribed me Paxlovid.
Age: 76.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive
Clinical narrative: Diagnosed with Covid-19 on 2/14/2023.
Age: 33.0
Sex: F
Vaccine: HPV9
Symptoms: Immediate post-injection reaction, Presyncope
Clinical narrative: Immediate vasovagal response. She was treated at the scene by EMS and released. She came back into the pharmacy to pick up her receipt and seemed fine. She had indicated in her form that she had previous dizziness after vaccines, however she stated that it was mild. Allergic to pcn, latex and contrast dye. This vaccine is packaged latex-free.
Age: 61.0
Sex: F
Vaccine: COVID19-2
Symptoms: Brain fog, COVID-19, Fatigue, Oropharyngeal pain, Periorbital swelling
Clinical narrative: On Christmas day 2022, late in the day, I started feeling very fatigued with a scratchy throat. My eyes also felt very small and puffy. The next morning, I had a head congestion, fever and sore throat. As the day progressed, it moved to my chest. I tested positive for COVID-19 with a home test. I realized I also had brain fog as if everything was in slow motion. I sent a message to my doctor. I began taking the antiviral on the 27th and by Thursday I began feeling better. The following Monday, I tested negative. I feel like I am completely recovered but my brain fog lasted another 10 days.
Age: 61.0
Sex: F
Vaccine: COVID19-2
Symptoms: Pyrexia, Respiratory tract congestion, SARS-CoV-2 test positive, Throat irritation
Clinical narrative: On Christmas day 2022, late in the day, I started feeling very fatigued with a scratchy throat. My eyes also felt very small and puffy. The next morning, I had a head congestion, fever and sore throat. As the day progressed, it moved to my chest. I tested positive for COVID-19 with a home test. I realized I also had brain fog as if everything was in slow motion. I sent a message to my doctor. I began taking the antiviral on the 27th and by Thursday I began feeling better. The following Monday, I tested negative. I feel like I am completely recovered but my brain fog lasted another 10 days.
Age: 56.0
Sex: F
Vaccine: COVID19-2
Symptoms: Headache, Therapy change, Ultrasound kidney normal
Clinical narrative: I have had high blood pressure in the past but it has been steady for years. In January I started to have a headache so I checked my blood pressure and it was 156 over 95. I went to go see my doctor 01/05/2023 and she increased my losartan dose. It did not help enough so I she added more medications to see if that works.
Age: 45.0
Sex: F
Vaccine: COVID19-2
Symptoms: Incorrect product formulation administered
Clinical narrative: No symptoms or side effects, patient left fine. adverse event was that patient was given a Pfizer bivalent dose instead of Pfizer monovalent to replace the Moderna monovalent 2nd dose.
Age: 78.0
Sex: M
Vaccine: VARZOS
Symptoms: Gait inability, Guillain-Barre syndrome, Immunisation reaction, Immunoglobulin therapy
Clinical narrative: Patient was diagnosed with Guillain Barre syndrome 2/15/22 at Hospital and was told likely due to shingles vaccine received in January. Patient received IVIG treatment and upon improvement was discharged to rehab facility on 2/23/22. Completed approximately 30 days of rehab and was discharged able to walk again.
Age: 71.0
Sex: F
Vaccine: VARZOS
Symptoms: Asthenia, Feeling hot, Headache, Mobility decreased, Syncope
Clinical narrative: Extremely hot, then feeling weak, then fainted, threw up, all in a short period of time. Headache for about 2 hours afterwards. Bed rest.
Age: 71.0
Sex: F
Vaccine: VARZOS
Symptoms: Vomiting
Clinical narrative: Extremely hot, then feeling weak, then fainted, threw up, all in a short period of time. Headache for about 2 hours afterwards. Bed rest.
Age: 1.08
Sex: M
Vaccine: HEPA
Symptoms: Extra dose administered
Clinical narrative: Patient was administer Hep A dose 1 on 2/24/23. There was an error in documentation and the patient was administer Hep A again on 03/24/23.
Age: 36.0
Sex: M
Vaccine: FLU4, TDAP
Symptoms: Acoustic stimulation tests abnormal, Deafness neurosensory, Dizziness, Ear discomfort, Injection site pain
Clinical narrative: On 2/19/2023 at 1:15 pm, I received both the flu vaccine and Tdap. The following morning at 5 am, I experienced symptoms including bilateral ringing, also known as tinnitus,  pain in both arms at the injection sites, and dizziness. Over the next few days, the tinnitus went from bilateral to unilateral moving to my left ear, and I also experienced fullness in that ear. Despite attempts to schedule appointments with several ENT doctors, I was only able to secure an appointment on 3/6/2023. During the appointment, I underwent a hearing test which revealed SSHL. The doctor recommended a series of 3-4 tympanic steroid injections and oral prednisone. Since then, I have received three tympanic steroid injections and completed a 14-day course of prednisone, but I continue to experience tinnitus in my left ear and SSHL.
Age: 36.0
Sex: M
Vaccine: FLU4, TDAP
Symptoms: Sudden hearing loss, Tinnitus
Clinical narrative: On 2/19/2023 at 1:15 pm, I received both the flu vaccine and Tdap. The following morning at 5 am, I experienced symptoms including bilateral ringing, also known as tinnitus,  pain in both arms at the injection sites, and dizziness. Over the next few days, the tinnitus went from bilateral to unilateral moving to my left ear, and I also experienced fullness in that ear. Despite attempts to schedule appointments with several ENT doctors, I was only able to secure an appointment on 3/6/2023. During the appointment, I underwent a hearing test which revealed SSHL. The doctor recommended a series of 3-4 tympanic steroid injections and oral prednisone. Since then, I have received three tympanic steroid injections and completed a 14-day course of prednisone, but I continue to experience tinnitus in my left ear and SSHL.
Age: 25.0
Sex: M
Vaccine: FLU4, HEP
Symptoms: Syncope
Clinical narrative: PATIENT FAINTED SOME MINUTES AFTER GETTING THE IMMUNIZATIONS (SYNCOPE). WE CALLED EMERGENCY SERVIES AND THE PARAMEDICS CAME AND CHECKED ON HIM. HE WAS GIVING THE CLEAR AND DIDNT NEED TO GO TO THE HOSPITAL
Age: 1.67
Sex: M
Vaccine: COVID19
Symptoms: Incorrect product formulation administered
Clinical narrative: A third dose of monovalent MODERNA 6 months to 5 years was administered instead of a bivalent dose.
Age: 93.0
Sex: F
Vaccine: FLUA4
Symptoms: Extra dose administered
Clinical narrative: Patient received 2nd dose of senior dose flu vaccine.
Age: 34.0
Sex: F
Vaccine: FLU4
Symptoms: Extra dose administered
Clinical narrative: Received the 2nd flu vaccine within the same season.
Age: 59.0
Sex: F
Vaccine: VARZOS
Symptoms: Erythema, Peripheral swelling, Skin warm
Clinical narrative: Patient has redness, swelling  of left arm. Also arm is warm to touch.
Age: 52.0
Sex: F
Vaccine: PNC20, VARZOS
Symptoms: Activated partial thromboplastin time, Anti-thyroid antibody, Asthenia, Blood glucose, Blood ketone body
Clinical narrative: The same day (1/31/23) of the vaccines pt. had weak and tingly legs, someone else had to drive her home.   Throughout a week the numbness started getting worse on pt.'s left side and she went to an outpatient center which diagnosed her with a pinched nerve due to her hernia history. (2/8/23)  The next day I (son) noticed signs of stroke (left paralysis and neglect, weakness, confusion) and rushed her to the hospital (2/9/23) where they cleared her via CT scan + inpatient stay (2/10/23). There was no MRI done. They discharged with reasons of hyperglycemia since they could not determine a TIA stroke had occured.  A few days later (2/13/23) pt.'s left side was worse with complete left paralysis and left neglect. After 5 days of hospital tests and observations she was discharged to a rehab - where she is still at - to recover from multiple strokes.
Age: 52.0
Sex: F
Vaccine: PNC20, VARZOS
Symptoms: Blood lactic acid, Blood magnesium, Blood osmolarity, Blood phosphorus, Blood thyroid stimulating hormone
Clinical narrative: The same day (1/31/23) of the vaccines pt. had weak and tingly legs, someone else had to drive her home.   Throughout a week the numbness started getting worse on pt.'s left side and she went to an outpatient center which diagnosed her with a pinched nerve due to her hernia history. (2/8/23)  The next day I (son) noticed signs of stroke (left paralysis and neglect, weakness, confusion) and rushed her to the hospital (2/9/23) where they cleared her via CT scan + inpatient stay (2/10/23). There was no MRI done. They discharged with reasons of hyperglycemia since they could not determine a TIA stroke had occured.  A few days later (2/13/23) pt.'s left side was worse with complete left paralysis and left neglect. After 5 days of hospital tests and observations she was discharged to a rehab - where she is still at - to recover from multiple strokes.
Age: 52.0
Sex: F
Vaccine: PNC20, VARZOS
Symptoms: Cerebrovascular accident, Cognitive disorder, Computerised tomogram head, Computerised tomogram head normal, Computerised tomogram spine
Clinical narrative: The same day (1/31/23) of the vaccines pt. had weak and tingly legs, someone else had to drive her home.   Throughout a week the numbness started getting worse on pt.'s left side and she went to an outpatient center which diagnosed her with a pinched nerve due to her hernia history. (2/8/23)  The next day I (son) noticed signs of stroke (left paralysis and neglect, weakness, confusion) and rushed her to the hospital (2/9/23) where they cleared her via CT scan + inpatient stay (2/10/23). There was no MRI done. They discharged with reasons of hyperglycemia since they could not determine a TIA stroke had occured.  A few days later (2/13/23) pt.'s left side was worse with complete left paralysis and left neglect. After 5 days of hospital tests and observations she was discharged to a rehab - where she is still at - to recover from multiple strokes.
Age: 52.0
Sex: F
Vaccine: PNC20, VARZOS
Symptoms: Condition aggravated, Confusional state, Culture urine, Differential white blood cell count, Electrocardiogram
Clinical narrative: The same day (1/31/23) of the vaccines pt. had weak and tingly legs, someone else had to drive her home.   Throughout a week the numbness started getting worse on pt.'s left side and she went to an outpatient center which diagnosed her with a pinched nerve due to her hernia history. (2/8/23)  The next day I (son) noticed signs of stroke (left paralysis and neglect, weakness, confusion) and rushed her to the hospital (2/9/23) where they cleared her via CT scan + inpatient stay (2/10/23). There was no MRI done. They discharged with reasons of hyperglycemia since they could not determine a TIA stroke had occured.  A few days later (2/13/23) pt.'s left side was worse with complete left paralysis and left neglect. After 5 days of hospital tests and observations she was discharged to a rehab - where she is still at - to recover from multiple strokes.
Age: 52.0
Sex: F
Vaccine: PNC20, VARZOS
Symptoms: Full blood count, Glomerular filtration rate, Glycosylated haemoglobin, Hemiplegia, Hernia
Clinical narrative: The same day (1/31/23) of the vaccines pt. had weak and tingly legs, someone else had to drive her home.   Throughout a week the numbness started getting worse on pt.'s left side and she went to an outpatient center which diagnosed her with a pinched nerve due to her hernia history. (2/8/23)  The next day I (son) noticed signs of stroke (left paralysis and neglect, weakness, confusion) and rushed her to the hospital (2/9/23) where they cleared her via CT scan + inpatient stay (2/10/23). There was no MRI done. They discharged with reasons of hyperglycemia since they could not determine a TIA stroke had occured.  A few days later (2/13/23) pt.'s left side was worse with complete left paralysis and left neglect. After 5 days of hospital tests and observations she was discharged to a rehab - where she is still at - to recover from multiple strokes.
Age: 52.0
Sex: F
Vaccine: PNC20, VARZOS
Symptoms: Hyperglycaemia, Hypoaesthesia, Impaired driving ability, International normalised ratio, Lipids
Clinical narrative: The same day (1/31/23) of the vaccines pt. had weak and tingly legs, someone else had to drive her home.   Throughout a week the numbness started getting worse on pt.'s left side and she went to an outpatient center which diagnosed her with a pinched nerve due to her hernia history. (2/8/23)  The next day I (son) noticed signs of stroke (left paralysis and neglect, weakness, confusion) and rushed her to the hospital (2/9/23) where they cleared her via CT scan + inpatient stay (2/10/23). There was no MRI done. They discharged with reasons of hyperglycemia since they could not determine a TIA stroke had occured.  A few days later (2/13/23) pt.'s left side was worse with complete left paralysis and left neglect. After 5 days of hospital tests and observations she was discharged to a rehab - where she is still at - to recover from multiple strokes.
Age: 52.0
Sex: F
Vaccine: PNC20, VARZOS
Symptoms: Metabolic function test, Microscopy, Muscular weakness, Nerve compression, Neurologic neglect syndrome
Clinical narrative: The same day (1/31/23) of the vaccines pt. had weak and tingly legs, someone else had to drive her home.   Throughout a week the numbness started getting worse on pt.'s left side and she went to an outpatient center which diagnosed her with a pinched nerve due to her hernia history. (2/8/23)  The next day I (son) noticed signs of stroke (left paralysis and neglect, weakness, confusion) and rushed her to the hospital (2/9/23) where they cleared her via CT scan + inpatient stay (2/10/23). There was no MRI done. They discharged with reasons of hyperglycemia since they could not determine a TIA stroke had occured.  A few days later (2/13/23) pt.'s left side was worse with complete left paralysis and left neglect. After 5 days of hospital tests and observations she was discharged to a rehab - where she is still at - to recover from multiple strokes.
Age: 52.0
Sex: F
Vaccine: PNC20, VARZOS
Symptoms: Neurological symptom, Paraesthesia, Prothrombin time, Respiratory viral panel, SARS-CoV-2 test
Clinical narrative: The same day (1/31/23) of the vaccines pt. had weak and tingly legs, someone else had to drive her home.   Throughout a week the numbness started getting worse on pt.'s left side and she went to an outpatient center which diagnosed her with a pinched nerve due to her hernia history. (2/8/23)  The next day I (son) noticed signs of stroke (left paralysis and neglect, weakness, confusion) and rushed her to the hospital (2/9/23) where they cleared her via CT scan + inpatient stay (2/10/23). There was no MRI done. They discharged with reasons of hyperglycemia since they could not determine a TIA stroke had occured.  A few days later (2/13/23) pt.'s left side was worse with complete left paralysis and left neglect. After 5 days of hospital tests and observations she was discharged to a rehab - where she is still at - to recover from multiple strokes.
Age: 52.0
Sex: F
Vaccine: PNC20, VARZOS
Symptoms: Syncope, Thyroxine free, Tri-iodothyronine free, Troponin I, Urine analysis
Clinical narrative: The same day (1/31/23) of the vaccines pt. had weak and tingly legs, someone else had to drive her home.   Throughout a week the numbness started getting worse on pt.'s left side and she went to an outpatient center which diagnosed her with a pinched nerve due to her hernia history. (2/8/23)  The next day I (son) noticed signs of stroke (left paralysis and neglect, weakness, confusion) and rushed her to the hospital (2/9/23) where they cleared her via CT scan + inpatient stay (2/10/23). There was no MRI done. They discharged with reasons of hyperglycemia since they could not determine a TIA stroke had occured.  A few days later (2/13/23) pt.'s left side was worse with complete left paralysis and left neglect. After 5 days of hospital tests and observations she was discharged to a rehab - where she is still at - to recover from multiple strokes.
Age: 36.0
Sex: F
Vaccine: COVID19-2
Symptoms: Arthralgia, Fatigue, Headache, Myalgia, Pyrexia
Clinical narrative: Fever, headache, joint aches, muscle aches, fatigue
Age: 73.0
Sex: F
Vaccine: COVID19-2
Symptoms: Angiocardiogram, Bundle branch block left, Cardiac failure, Cardiomegaly, Cardiomyopathy
Clinical narrative: It is unknown if this condition and hospitalization is related to the SARS-CoV-2 vaccine.  I developed Left lung congestion, wheezing, crackles.  Treated with bronchodilator without relief.  Chest CT on 1/9/23 showed pulmonary edema in the right lung and trace effusion.  Symptoms persisted for weeks, echocardiogram performed on 1/24/23 showed left ventricular dysfunction with ejection fraction of 15-20%.  Hospitalized at Medical Center for 4 days.  Cardiac catherterization/angiogram result = no blockages.  Diagnosis = heart failure.
Age: 73.0
Sex: F
Vaccine: COVID19-2
Symptoms: Catheterisation cardiac abnormal, Computerised tomogram thorax abnormal, Crepitations, Echocardiogram abnormal, Ejection fraction decreased
Clinical narrative: It is unknown if this condition and hospitalization is related to the SARS-CoV-2 vaccine.  I developed Left lung congestion, wheezing, crackles.  Treated with bronchodilator without relief.  Chest CT on 1/9/23 showed pulmonary edema in the right lung and trace effusion.  Symptoms persisted for weeks, echocardiogram performed on 1/24/23 showed left ventricular dysfunction with ejection fraction of 15-20%.  Hospitalized at Medical Center for 4 days.  Cardiac catherterization/angiogram result = no blockages.  Diagnosis = heart failure.